Charcoal tablets in the treatment of patients with irritable bowel syndrome

Advances in Therapy

Volumn 19, Issue 5, 2002, Pages 245-252

  Hübner, Wolf D ^a   Moser, Ewald H ^b  

^a Berolina Drug Development GmbH   (Germany)

^b F Trenka Chem Pharm Fabrik GmbH   (Austria)

Author keywords

Controlled trial; Irritable bowel syndrome; Nonactivated charcoal

Indexed keywords

CHARCOAL; EUCARBON;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; IRRITABLE COLON; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHASE 3 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; RHUBARB; SENNA; SIDE EFFECT; TREATMENT OUTCOME;

EID: 0036766221     PISSN: 0741238X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02850364     Document Type: Article

References (7)

1. Carlson E. Irritable bowel syndrome. Nurse Pract. 1998;23:82-91.
2. Thompson WG, Gick M. Irritable bowel syndrome. Semin Gastrointest Dis. 1996;7:217-229.
3. Chassany O, Marquis P, Scherrer B, et al. Validation of a specific quality of life questionnaire for functional digestive disorders. Gut. 1999;44:527-533.
4. Battaglia G, Morselli-Labate AM, Camarri E, et al. Otilonium bromide in irritable bowel syndrome: a double-blind, placebo-controlled, 15-week study. Aliment Pharmacol Ther. 1998;12:1003-1010.
5. Talley NJ, Zinsmeister AR, Melton LJ III. Irritable bowel syndrome in a community: symptom subgroups, risk factors, and health care utilization. Am J Epidemiol. 1995;142:76-83.
6. Liu JH, Chen GH, Yeh HZ, Huang CK, Poon SK. Enteric-coated peppermint-oil capsules in the treatment of irritable bowel syndrome: a prospective, randomized trial. J Gastroenterol. 1997;32:765-768.
7. Francis CY, Morris J, Whorwell PJ. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther. 1997;11:395-402.